200 related articles for article (PubMed ID: 23539408)
21. Sex differences in performance of fecal occult blood testing.
Brenner H; Haug U; Hundt S
Am J Gastroenterol; 2010 Nov; 105(11):2457-64. PubMed ID: 20700114
[TBL] [Abstract][Full Text] [Related]
22. Considering colorectal screening.
Mitchell T
CMAJ; 2003 Apr; 168(9):1110; author reply 1112-3. PubMed ID: 12719304
[No Abstract] [Full Text] [Related]
23. Clinical and programmatic costs of implementing colorectal cancer screening: evaluation of five programs.
Subramanian S; Tangka FK; Hoover S; Degroff A; Royalty J; Seeff LC
Eval Program Plann; 2011 May; 34(2):147-53. PubMed ID: 21036399
[TBL] [Abstract][Full Text] [Related]
24. [Colorectal neoplasm, screening and pluralism].
Hadengue A
Rev Med Suisse; 2010 Sep; 6(261):1635-6. PubMed ID: 20939395
[No Abstract] [Full Text] [Related]
25. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening.
Park DI; Ryu S; Kim YH; Lee SH; Lee CK; Eun CS; Han DS
Am J Gastroenterol; 2010 Sep; 105(9):2017-25. PubMed ID: 20502450
[TBL] [Abstract][Full Text] [Related]
26. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
[TBL] [Abstract][Full Text] [Related]
27. High yield of colorectal neoplasia detected by colonoscopy following a positive faecal occult blood test in the NHS Bowel Cancer Screening Programme.
Lee TJ; Clifford GM; Rajasekhar P; Rutter MD; Kometa S; Ritchie MC; Waddup G; Nylander D; McNally RJ; Rees CJ
J Med Screen; 2011; 18(2):82-6. PubMed ID: 21852700
[TBL] [Abstract][Full Text] [Related]
28. A retrospective study of immunochemical fecal occult blood testing for colorectal cancer detection.
Oono Y; Iriguchi Y; Doi Y; Tomino Y; Kishi D; Oda J; Takayanagi S; Mizutani M; Fujisaki T; Yamamura A; Hosoi T; Taguchi H; Kosaka M; Delgado P
Clin Chim Acta; 2010 Jun; 411(11-12):802-5. PubMed ID: 20184867
[TBL] [Abstract][Full Text] [Related]
29. [The effect of primary colonoscopy versus follow-up colonoscopy in screening for colorectal cancer].
Krøijer R; Baatrup G
Ugeskr Laeger; 2019 Feb; 181(7):. PubMed ID: 30777594
[TBL] [Abstract][Full Text] [Related]
30. Fecal occult blood testing.
Sanford KW; McPherson RA
Clin Lab Med; 2009 Sep; 29(3):523-41. PubMed ID: 19840685
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the occult blood test in screening for colorectal neoplasms. A prospective study using flexible endoscopy.
Reilly JM; Ballantyne GH; Fleming FX; Zucker KA; Modlin IM
Am Surg; 1990 Mar; 56(3):119-23. PubMed ID: 2316930
[TBL] [Abstract][Full Text] [Related]
32. [Colorectal cancer screening. Where are we?].
Benhaberou-Brun D
Perspect Infirm; 2013; 10(3):52-5. PubMed ID: 23710531
[No Abstract] [Full Text] [Related]
33. New fecal occult blood tests may improve adherence and mortality rates.
Kumaravel V; Hayden SP; Hall GS; Burke CA
Cleve Clin J Med; 2011 Aug; 78(8):515-20. PubMed ID: 21807923
[TBL] [Abstract][Full Text] [Related]
34. [Colonoscopy for early detection and prevention of colorectal cancer].
Niv Y
Harefuah; 2010 Aug; 149(8):535-6, 549. PubMed ID: 21341435
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic yield of a one sample immunochemical test at different cut-off values in an organised screening programme for colorectal cancer.
Hamza S; Dancourt V; Lejeune C; Bidan JM; Lepage C; Faivre J
Eur J Cancer; 2013 Aug; 49(12):2727-33. PubMed ID: 23601670
[TBL] [Abstract][Full Text] [Related]
36. [A clear view in colonoscopy. Effective bowel cleansing: essential for successful colorectal cancer screening].
Mundt M
MMW Fortschr Med; 2014 Dec; 156(21-22):94-5. PubMed ID: 25608419
[No Abstract] [Full Text] [Related]
37. Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood test.
Oort FA; Terhaar Sive Droste JS; Van Der Hulst RW; Van Heukelem HA; Loffeld RJ; Wesdorp IC; Van Wanrooij RL; De Baaij L; Mutsaers ER; van der Reijt S; Coupe VM; Berkhof J; Bouman AA; Meijer GA; Mulder CJ
Aliment Pharmacol Ther; 2010 Feb; 31(3):432-9. PubMed ID: 19878150
[TBL] [Abstract][Full Text] [Related]
38. [Colorectal cancer screening].
Castells A
Gastroenterol Hepatol; 2012 Sep; 35 Suppl 1():68-73. PubMed ID: 23018010
[TBL] [Abstract][Full Text] [Related]
39. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
[TBL] [Abstract][Full Text] [Related]
40. [Screening colonoscopy for early detection of intestinal cancer].
Mader U
Dtsch Med Wochenschr; 2003 Mar; 128(12):596. PubMed ID: 12685432
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
